0,845  0,004  Tubulin antagonist
0,766  0,009  Antineoplastic (colorectal cancer)
0,765  0,009  Antineoplastic (colon cancer)
0,743  0,002  Beta tubulin antagonist
0,657  0,026  Antineoplastic (breast cancer)
0,639  0,025  Antineoplastic (lung cancer)
0,581  0,026  Antineoplastic (solid tumors)
0,559  0,015  Cytostatic
0,540  0,010  Antimitotic
0,526  0,012  Tumour necrosis factor alpha release inhibitor
0,516  0,015  Antiamyloidogenic
0,506  0,007  Antineoplastic (squamous cell carcinoma)
0,501  0,004  Alpha tubulin antagonist
0,523  0,041  TNF expression inhibitor
0,521  0,052  Caspase 9 stimulant
0,495  0,028  Antineoplastic (ovarian cancer)
0,489  0,024  Antineoplastic (cervical cancer)
0,489  0,034  Prostate cancer treatment
0,441  0,011  Antineoplastic (carcinoma)
0,496  0,076  Apoptosis agonist
0,424  0,012  Muscle relaxant
0,442  0,032  Antineoplastic (melanoma)
0,412  0,017  Antineoplastic (lymphocytic leukemia)
0,425  0,037  Caspase 3 stimulant
0,438  0,053  Antileukemic
0,405  0,021  Myocardial infarction treatment
0,409  0,030  NOS2 expression inhibitor
0,380  0,040  Antineoplastic (glioma)
0,377  0,039  Cytotoxic
0,371  0,038  UGT2B4 substrate
0,356  0,049  CYP1A2 substrate
0,319  0,018  Skeletal muscle relaxant
0,353  0,052  Spasmolytic
0,384  0,084  Antibacterial
0,324  0,060  Antineoplastic (pancreatic cancer)
0,275  0,021  Topoisomerase II inhibitor
0,264  0,025  MAO inhibitor
0,285  0,052  Antineoplastic (glioblastoma multiforme)
0,285  0,053  Antineoplastic (bladder cancer)
0,316  0,087  Transcription factor NF kappa B inhibitor
0,286  0,063  Antineoplastic (non-small cell lung cancer)
0,271  0,054  Antineoplastic (sarcoma)
0,244  0,028  Muscular dystrophy treatment
0,236  0,024  Acetylcholinesterase inhibitor
0,231  0,026  Genotoxic
0,306  0,102  Cognition disorders treatment
0,271  0,070  DNA damaging
0,331  0,131  Antiarthritic
0,311  0,117  CYP2C19 inhibitor
0,295  0,103  CYP3A4 substrate
0,228  0,035  Cholinergic
0,239  0,051  UGT1A1 substrate
0,241  0,056  Mutagenic
0,279  0,095  Antineoplastic (brain cancer)
0,257  0,074  Teratogen
0,263  0,091  Lipoxygenase inhibitor
0,191  0,020  Bronchodilator
0,317  0,146  5 Hydroxytryptamine release inhibitor
0,203  0,034  Phobic disorders treatment
0,301  0,131  15-Lipoxygenase inhibitor
0,258  0,091  Antineoplastic (multiple myeloma)
0,196  0,029  DNA polymerase I inhibitor
0,216  0,055  P-glycoprotein inhibitor
0,198  0,038  UGT2B10 substrate
0,243  0,083  Antineoplastic (renal cancer)
0,290  0,131  Antiprotozoal
0,219  0,063  Antiviral (Influenza)
0,165  0,010  Acetylcholine release stimulant
0,254  0,104  CYP2D6 substrate
0,181  0,031  Topoisomerase I inhibitor
0,193  0,047  Amylase inhibitor
0,149  0,005  Topoisomerase II beta inhibitor
0,270  0,131  CYP2C9 substrate
0,193  0,055  UGT1A3 substrate
0,183  0,046  Carcinogenic, group 1
0,168  0,036  DNA intercalator
0,160  0,030  Butyrylcholinesterase inhibitor
0,258  0,132  Antiprotozoal (Plasmodium)
0,195  0,072  Carcinogenic
0,211  0,089  Free radical scavenger
0,249  0,129  Sodium/bile acid cotransporter inhibitor
0,142  0,025  Topoisomerase II alpha inhibitor
0,217  0,103  Antioxidant
0,238  0,126  AR expression inhibitor
0,202  0,091  Embryotoxic
0,149  0,038  Microtubule formation inhibitor
0,210  0,099  Acute neurologic disorders treatment
0,202  0,092  Antineoplastic (lymphoma)
0,179  0,070  Antineoplastic (gastric cancer)
0,149  0,041  Beta amyloid protein antagonist
0,221  0,118  Respiratory analeptic
0,153  0,053  Skin whitener
0,203  0,105  Antineoplastic (liver cancer)
0,141  0,045  Antineoplastic (uterine cancer)
0,173  0,080  Nitric oxide antagonist
0,135  0,043  MAO B inhibitor
0,221  0,129  CYP2D6 inhibitor
0,126  0,035  Alpha 2 adrenoreceptor antagonist
0,160  0,070  Melanin inhibitor
0,129  0,041  Myasthenia Gravis treatment
0,109  0,023  Lipase inhibitor
0,181  0,100  Cardiodepressant
0,082  0,005  Aggrecanase 1 inhibitor
0,125  0,050  MAO A inhibitor
0,115  0,040  5 Hydroxytryptamine 2A antagonist
0,104  0,031  Dopamine D2 antagonist
0,183  0,110  UGT1A6 substrate
0,198  0,130  UGT1A9 substrate
0,162  0,095  LDLR expression enhancer
0,186  0,121  RNA-directed DNA polymerase inhibitor
0,144  0,079  Antiviral (Influenza A)
0,230  0,166  Immunosuppressant
0,116  0,052  Electron transport complex I inhibitor
0,116  0,053  Vasculitis treatment
0,199  0,137  Tyrosine 3 hydroxylase inhibitor
0,184  0,123  Antidiabetic symptomatic
0,157  0,097  DNA methyltransferase I inhibitor
0,096  0,040  Dopamine antagonist
0,163  0,110  CYP2B6 inhibitor
0,087  0,037  CDC25A inhibitor
0,190  0,143  CYP1A2 inhibitor
0,130  0,085  UGT2B15 substrate
0,055  0,011  Antibiotic Aminoglycoside-like
0,078  0,034  Dopamine D3 antagonist
0,187  0,144  Cardioprotectant
0,142  0,100  Male reproductive disfunction treatment
0,100  0,058  UGT2B11 substrate
0,112  0,070  Sphingosine 1-phosphate receptor 2 agonist
0,106  0,067  5 Hydroxytryptamine 2 antagonist
0,211  0,172  GST M1-1 substrate
0,166  0,127  Antiprotozoal (Leishmania)
0,064  0,026  5 Hydroxytryptamine 7 agonist
0,071  0,036  Beta adrenoreceptor antagonist
0,244  0,212  Calcium channel L-type activator
0,122  0,091  Hair growth stimulant
0,146  0,117  UDP-glucuronosyltransferase substrate
0,148  0,119  DNA methylase inhibitor
0,183  0,155  Chemoprotective
0,143  0,117  Hepatoprotectant
0,161  0,136  Antihypercholesterolemic
0,160  0,136  Antineoplastic enhancer
0,075  0,052  Antibiotic
0,034  0,011  Protein 30S ribosomal subunit inhibitor
0,079  0,058  Antineoplastic antibiotic
0,098  0,080  Chelator
0,153  0,136  Aldehyde oxidase inhibitor
0,113  0,097  Antimutagenic
0,109  0,094  Coagulant
0,084  0,069  ATPase (Vacuolar H+) inhibitor
0,019  0,005  Antibiotic Tetracycline-like
0,078  0,065  Calcium antagonist
0,077  0,064  Phosphodiesterase IV inhibitor
0,103  0,092  Growth stimulant
0,121  0,110  Antiviral (Herpes)
0,057  0,048  5 Hydroxytryptamine 7 antagonist
0,091  0,084  Alpha 2b adrenoreceptor antagonist
0,208  0,202  Calcium channel activator
0,163  0,160  Analeptic
0,156  0,154  VEGF expression inhibitor
0,150  0,149  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,045  0,044  Beta 2 adrenoreceptor antagonist
0,055  0,054  Potassium channel (Ca-activated) blocker

